GART Inhibitors

GART (Phosphoribosylglycinamide Formyltransferase) Inhibitors comprise a class of chemical compounds designed to selectively target and modulate the activity of the GART enzyme. GART is a key enzyme involved in the de novo purine nucleotide biosynthesis pathway, a fundamental metabolic process responsible for the synthesis of purine nucleotides essential for DNA and RNA synthesis, as well as other cellular functions. GART catalyzes the conversion of phosphoribosylglycinamide (GAR) to phosphoribosylglycinamide formyltransferase (FGAR), a critical step in purine biosynthesis. Inhibition of GART can disrupt this pathway, leading to a reduced availability of purine nucleotides and affecting various cellular processes that rely on nucleotide pools.

GART inhibitors are designed to interact with the enzyme's active site, interfering with its catalytic function. By binding to GART and inhibiting its enzymatic activity, these inhibitors can modulate the rate of purine nucleotide production within the cell. This modulation can have far-reaching consequences on cellular processes such as DNA replication, RNA synthesis, and energy metabolism, as purine nucleotides are essential components in these pathways. Researchers study GART inhibitors to gain insights into the regulation of purine biosynthesis and its implications for cellular physiology.